256 related articles for article (PubMed ID: 33563177)
1. Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells.
Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
[TBL] [Abstract][Full Text] [Related]
2. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
[TBL] [Abstract][Full Text] [Related]
3. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
[TBL] [Abstract][Full Text] [Related]
4. Mammary gland stem cells and their application in breast cancer.
Yang X; Wang H; Jiao B
Oncotarget; 2017 Feb; 8(6):10675-10691. PubMed ID: 27793013
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract][Full Text] [Related]
8. Chromatin remodeling in mammary gland differentiation and breast tumorigenesis.
Huang TH; Esteller M
Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004515. PubMed ID: 20610549
[TBL] [Abstract][Full Text] [Related]
9. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.
Wen S; Qin Y; Wang R; Yang L; Zeng H; Zhu P; Li Q; Qiu Y; Chen S; Liu Y; Hou Y; Tang X; Liu M; Tu G
Cell Death Dis; 2021 May; 12(5):437. PubMed ID: 33934099
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic and metabolic regulation of breast cancer stem cells.
Liu HX; Li XL; Dong CF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
[TBL] [Abstract][Full Text] [Related]
11. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells.
Flores-Huerta N; Silva-Cázares MB; Arriaga-Pizano LA; Prieto-Chávez JL; López-Camarillo C
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802575
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
14. Role of epigenetic modulation in cancer stem cell fate.
Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
18. Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1.
Zhang T; Zhang W; Hao M
Oncol Rep; 2021 Jan; 45(1):337-348. PubMed ID: 33416137
[TBL] [Abstract][Full Text] [Related]
19. Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells.
Samadani AA; Norollahi SE; Rashidy-Pour A; Mansour-Ghanaei F; Nemati S; Joukar F; Afshar AM; Ghazanfari S; Safizadeh M; Rostami P; Gatei M
Biomed Pharmacother; 2018 Dec; 108():590-599. PubMed ID: 30243093
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
